-
1 Comment
Provexis plc is currently in a long term uptrend where the price is trading 12.0% above its 200 day moving average.
From a valuation standpoint, the stock is 97.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 38.4.
Provexis plc's total revenue sank by 0.0% to $111K since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-75K since the same quarter in the previous year.
Finally, its free cash flow grew by 11.4% to $-68K since the same quarter in the previous year.
Based on the above factors, Provexis plc gets an overall score of 3/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| ISIN | GB00B0923P27 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Market Cap | 15M |
| Beta | 0.92 |
| Dividend Yield | None |
Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through company's website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NZCA.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
